![TACROLIMUS 0.1% IN PSEUDOCATALASE CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/874b82c6-ef05-8ce2-e053-2a95a90a5695/2174-2 end.jpg)
![TACROLIMUS 0.1% IN PSEUDOCATALASE CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/874b82c6-ef05-8ce2-e053-2a95a90a5695/2174-2 front.jpg)
![TACROLIMUS 0.1% IN PSEUDOCATALASE CREAM [SINCERUS FLORIDA, LLC]](https://medic.hrt.org//dailymed/images/874b82c6-ef05-8ce2-e053-2a95a90a5695/2174-2 middle.jpg)
- Directions for use
- Sincerus Florida, LLC adverse reactions.
- Active, inactive
- NDC 72934-2174-2 / TACROLIMUS USP 0.1%. Cream 30gm
-
INGREDIENTS AND APPEARANCE
TACROLIMUS 0.1% IN PSEUDOCATALASE
tacrolimus 0.1% in pseudocatalase creamProduct Information Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:72934-2174 Route of Administration TOPICAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength TACROLIMUS (UNII: WM0HAQ4WNM) (TACROLIMUS ANHYDROUS - UNII:Y5L2157C4J) TACROLIMUS ANHYDROUS 0.1 g in 100 g Product Characteristics Color white Score Shape Size Flavor Imprint Code Contains Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:72934-2174-2 30 g in 1 BOTTLE, PUMP; Type 0: Not a Combination Product 05/01/2019 Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date unapproved drug other 05/01/2019 Labeler - Sincerus Florida, LLC (080105003) Establishment Name Address ID/FEI Business Operations Sincerus Florida, LLC 080105003 manufacture(72934-2174)
